Evolution Global Acquisition (EVOXU) Stock Analysis & Price (Updated Oct 15, 2026, 4:00 PM ET)
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.25, +0.29% vs the prior close of $10.22.
- Volume 871 shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EVOXU ends flat (+0.3%) to $10.25. Closed at $10.25, +0.29% vs the prior close of $10.22. Day range $10.23–$10.25, opened at $10.23.
EVOXU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — EVOXU ends flat (+0.3%) to $10.25
- Closed at $10.25, +0.29% vs the prior close of $10.22. Day range $10.23–$10.25, opened at $10.23.
- Volume was 871 shares, 1.7x its 50-day average of 510.
- Price is -0.1% vs its 50-day average ($10.26) and +0.4% vs its 200-day average ($10.21).
- 52-week range $9.83–$10.31; today's close sits at 87% of that range, 0.6% below the 52-week high.
Oct 14, 2026 — EVOXU ends flat (+0.1%) to $10.22 on 5.6x normal volume
- Closed at $10.22, +0.09% vs the prior close of $10.21. Day range $10.20–$10.23, opened at $10.23.
- Volume was 2.55K shares, 5.6x its 50-day average of 459 — unusually heavy trading.
- Price is -0.4% vs its 50-day average ($10.26) and +0.1% vs its 200-day average ($10.21).
- 52-week range $9.83–$10.31; today's close sits at 81% of that range, 0.9% below the 52-week high.
Oct 13, 2026 — EVOXU dips 0.5% to $10.21, a 1-month low, 16 down days in a row
- Closed at $10.21, -0.49% vs the prior close of $10.26. Day range $10.21–$10.21, opened at $10.21.
- Volume was 201 shares, 0.4x its 50-day average of 455 — lighter than usual.
- Price is -0.5% vs its 50-day average ($10.27) and +0.0% vs its 200-day average ($10.21).
- 52-week range $9.83–$10.31; today's close sits at 79% of that range, 1.0% below the 52-week high.
- That makes 16 straight losses.
Oct 12, 2026 — EVOXU ends flat (-0.2%) to $10.26, a 1-month low on 4.1x normal volume
- Closed at $10.26, -0.19% vs the prior close of $10.28. Day range $9.83–$10.26, opened at $10.26.
- Volume was 1.83K shares, 4.1x its 50-day average of 451 — unusually heavy trading.
- Price is -0.1% vs its 50-day average ($10.27) and +0.5% vs its 200-day average ($10.21).
- 52-week range $9.83–$10.31; today's close sits at 90% of that range, 0.5% below the 52-week high.
- That makes 15 straight losses.
Oct 9, 2026 — EVOXU ends flat (+0.0%) to $10.28, 14 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.1% vs its 50-day average ($10.27) and +0.7% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 14 straight losses.
Oct 8, 2026 — EVOXU ends flat (+0.0%) to $10.28, 13 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.1% vs its 50-day average ($10.27) and +0.7% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 13 straight losses.
Oct 7, 2026 — EVOXU ends flat (+0.0%) to $10.28, 12 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.1% vs its 50-day average ($10.26) and +0.8% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 12 straight losses.
Oct 6, 2026 — EVOXU ends flat (+0.0%) to $10.28, 11 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.2% vs its 50-day average ($10.26) and +0.8% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 11 straight losses.
Oct 5, 2026 — EVOXU ends flat (+0.0%) to $10.28, 10 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.2% vs its 50-day average ($10.26) and +0.8% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 10 straight losses.
Oct 2, 2026 — EVOXU ends flat (+0.0%) to $10.28, 9 down days in a row
- Closed at $10.28, +0.00% vs the prior close of $10.28. Day range $10.28–$10.28, opened at $10.28.
- Price is +0.2% vs its 50-day average ($10.26) and +0.8% vs its 200-day average ($10.20).
- 52-week range $9.91–$10.31; today's close sits at 92% of that range, 0.3% below the 52-week high.
- That makes 9 straight losses.
EVOXU latest news & SEC filings
Every SEC filing by or about EVOXU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $1.94M
Things to know before you trade EVOXU
- How much it moves: over the last 20 sessions the average daily move was 0.08% (largest 0.5%). That is a relatively calm stock.
- Liquidity: about 293 shares (≈$3.01K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.25 vs a range of $9.83–$10.31 (87% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 12, 2026; 10-Q May 12, 2026; 8-K May 6, 2026.
- Listing: Nasdaq · industry: Blank Checks.
EVOXU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.23 | 10.25 | 10.23 | 10.25 | 871 |
| Oct 14, 2026 | 10.23 | 10.23 | 10.20 | 10.22 | 2.55K |
| Oct 13, 2026 | 10.21 | 10.21 | 10.21 | 10.21 | 201 |
| Oct 12, 2026 | 10.26 | 10.26 | 9.83 | 10.26 | 1.83K |
| Oct 9, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 8, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 7, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 6, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 5, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 2, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Oct 1, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 30, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 29, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 28, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 25, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 24, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 23, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
| Sep 22, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 213 |
| Sep 21, 2026 | 10.31 | 10.31 | 10.31 | 10.31 | 201 |
| Sep 18, 2026 | 10.28 | 10.28 | 10.28 | 10.28 | 0 |
About Evolution Global Acquisition
Evolution Global Acquisition (EVOXU) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in GRAND CAYMAN. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2077954.
EVOXU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gavin Apter | Director | Dec 2, 2025 |
| Michael Bloom | Director | May 6, 2026 |
| Erez Ichilov | Director | Nov 10, 2025 |
| Matthew Ryan Langsford | Director | Nov 10, 2025 |
| Stephen Marc Silver | CEO and Chairman | Nov 12, 2025 |
| Ashley Elizabeth Zumwalt-Forbes | Chief Operating Officer | Nov 10, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Arthur Kuan-Lin Chen | Chief Financial Officer | Nov 10, 2025 |
| Stephen Marc Silver | CEO and Chairman | Nov 12, 2025 |
| Ashley Elizabeth Zumwalt-Forbes | Chief Operating Officer | Nov 10, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
EVOXU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $246.47M, total liabilities $9.87M, cash $842.43K (as of Jun 30, 2026).
EVOXU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EVOXU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.